These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 28820038)
1. Comparison of Clevidipine and Nicardipine for Acute Blood Pressure Reduction in Patients With Stroke. Allison TA; Bowman S; Gulbis B; Hartman H; Schepcoff S; Lee K J Intensive Care Med; 2019; 34(11-12):990-995. PubMed ID: 28820038 [TBL] [Abstract][Full Text] [Related]
3. Comparison of Clevidipine and Nicardipine for Acute Blood Pressure Reduction in Hemorrhagic Stroke. Saldana S; Breslin J; Hanify J; Heierman T; Larizadeh K; Sanchez M; Phipps W Neurocrit Care; 2022 Jun; 36(3):983-992. PubMed ID: 34904214 [TBL] [Abstract][Full Text] [Related]
4. Continuous-Infusion Labetalol vs Nicardipine for Hypertension Management in Stroke Patients. Hecht JP; Richards PG J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):460-465. PubMed ID: 29092768 [TBL] [Abstract][Full Text] [Related]
5. Comparison of premade clevidipine and pharmacy-prepared nicardipine in time to goal systolic blood pressure in acute cerebrovascular accident. Martini BE; Schalk AL Am J Health Syst Pharm; 2022 Apr; 79(9):e110-e116. PubMed ID: 34636881 [TBL] [Abstract][Full Text] [Related]
6. Early Achievement of Blood Pressure Lowering and Hematoma Growth in Acute Intracerebral Hemorrhage: Stroke Acute Management with Urgent Risk-Factor Assessment and Improvement-Intracerebral Hemorrhage Study. Yamaguchi Y; Koga M; Sato S; Yamagami H; Todo K; Okuda S; Okada Y; Kimura K; Shiokawa Y; Kamiyama K; Itabashi R; Hasegawa Y; Kario K; Fujita K; Kumamoto M; Kamimura T; Ando D; Ide T; Yoshimoto T; Shiozawa M; Matsubara S; Yoshimura S; Nagatsuka K; Toyoda K; Cerebrovasc Dis; 2018; 46(3-4):118-124. PubMed ID: 30199854 [TBL] [Abstract][Full Text] [Related]
8. Time to Blood Pressure Control Before Thrombolytic Therapy in Patients With Acute Ischemic Stroke: Comparison of Labetalol, Nicardipine, and Hydralazine. McKay C; Hall AB; Cortes J J Neurosci Nurs; 2015 Dec; 47(6):327-32. PubMed ID: 26528950 [TBL] [Abstract][Full Text] [Related]
9. Effectiveness and safety of nicardipine and labetalol infusion for blood pressure management in patients with intracerebral and subarachnoid hemorrhage. Ortega-Gutierrez S; Thomas J; Reccius A; Agarwal S; Lantigua H; Li M; Carpenter AM; Mayer SA; Schmidt JM; Lee K; Claassen J; Badjatia N; Lesch C Neurocrit Care; 2013 Feb; 18(1):13-9. PubMed ID: 23055089 [TBL] [Abstract][Full Text] [Related]
10. Intensive Blood Pressure Lowering in Patients with Moderate to Severe Grade Acute Cerebral Hemorrhage: Post Hoc Analysis of Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH)-2 Trial. Qureshi AI; Foster LD; Lobanova I; Huang W; Suarez JI Cerebrovasc Dis; 2020; 49(3):244-252. PubMed ID: 32585668 [TBL] [Abstract][Full Text] [Related]
11. A comparison of nicardipine and labetalol for acute hypertension management following stroke. Liu-Deryke X; Janisse J; Coplin WM; Parker D; Norris G; Rhoney DH Neurocrit Care; 2008; 9(2):167-76. PubMed ID: 18250979 [TBL] [Abstract][Full Text] [Related]
12. Intravenous nicardipine dosing for blood pressure lowering in acute intracerebral hemorrhage: the Stroke Acute Management with Urgent Risk-factor Assessment and Improvement-Intracerebral Hemorrhage study. Koga M; Arihiro S; Hasegawa Y; Shiokawa Y; Okada Y; Kimura K; Furui E; Nakagawara J; Yamagami H; Kario K; Okuda S; Tokunaga K; Takizawa H; Takasugi J; Sato S; Nagatsuka K; Minematsu K; Toyoda K; J Stroke Cerebrovasc Dis; 2014; 23(10):2780-2787. PubMed ID: 25314943 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of the Efficacy and Safety of Nicardipine Versus Clevidipine for Blood Pressure Control in Hypertensive Crisis. Storey C; Pouliot J J Emerg Med; 2024 Oct; 67(4):e368-e374. PubMed ID: 39181839 [TBL] [Abstract][Full Text] [Related]
15. Clevidipine: a review of its use in the management of acute hypertension. Deeks ED; Keating GM; Keam SJ Am J Cardiovasc Drugs; 2009; 9(2):117-34. PubMed ID: 19331440 [TBL] [Abstract][Full Text] [Related]
16. Nicardipine Associated Risk of Short-Term Mortality in Critically Ill Patients with Ischemic Stroke. Sadeghi M; Saber H; Singh A; Hanni C; Parker D; Desai A; Mohamed W J Stroke Cerebrovasc Dis; 2019 May; 28(5):1168-1172. PubMed ID: 30683492 [TBL] [Abstract][Full Text] [Related]
17. Clevidipine Versus Nicardipine for Acute Blood Pressure Reduction in a Neuroscience Intensive Care Population. Finger JR; Kurczewski LM; Brophy GM Neurocrit Care; 2017 Apr; 26(2):167-173. PubMed ID: 27995512 [TBL] [Abstract][Full Text] [Related]
18. Clevidipine rapidly and safely reduces blood pressure in acute intracerebral hemorrhage: the ACCELERATE trial. Graffagnino C; Bergese S; Love J; Schneider D; Lazaridis C; LaPointe M; Lee K; Lynch G; Hu MY; Williams GC Cerebrovasc Dis; 2013; 36(3):173-80. PubMed ID: 24135526 [TBL] [Abstract][Full Text] [Related]
19. A prospective evaluation of labetalol versus nicardipine for blood pressure management in patients with acute stroke. Liu-DeRyke X; Levy PD; Parker D; Coplin W; Rhoney DH Neurocrit Care; 2013 Aug; 19(1):41-7. PubMed ID: 23760911 [TBL] [Abstract][Full Text] [Related]
20. Comparison of Nicardipine with Clevidipine in the Management of Hypertension in Acute Cerebrovascular Diseases. Rosenfeldt Z; Conklen K; Jones B; Ferrill D; Deshpande M; Siddiqui FM J Stroke Cerebrovasc Dis; 2018 Aug; 27(8):2067-2073. PubMed ID: 29627171 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]